Terazosin is a selective alpha 1 antagonist used for treatment of symptoms of prostate enlargement (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls. It is grouped under the following drug class(es): Alpha-1 Blockers. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Hytrin, Heitrin, Magnurol and Urodie. Its PubChem CID is 63016.
Terazosin hydrochloride dihydrate
| CAS No | 70024-40-7 |
|---|---|
| Molecular Formula | C19H30ClN5O6 |
| Molecular Weight | 459.9 g/mol |
| Synonyms | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Terazosin is a selective alpha 1 antagonist used for treatment of symptoms of prostate enlargement (BPH). It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement.
The listed CAS number is 70024-40-7.
The listed molecular formula is C19H30ClN5O6.
The listed molecular weight is 459.9 g/mol.
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride.
The source lists Hytrin, Heitrin, Magnurol and Urodie.